Agile Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference
15 February 2017 - 8:00AM
Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty
pharmaceutical company, announced today that its Chief Executive
Officer, Al Altomari will present at the RBC Capital Markets 2017
Global Healthcare Conference on February 23, 2017 at 10:00 AM ET at
the New York Palace in New York City.
To access the live and archived webcasts of the
presentation, visit the Investor Relations section of Agile
Therapeutics website at www.agiletherapeutics.com. The
webcast will be archived on Agile Therapeutics website for 60 days
following the event.
About Agile TherapeuticsAgile
Therapeutics is a forward-thinking women's healthcare company
dedicated to fulfilling the unmet health needs of today's women.
Our product candidates are designed to provide women with
contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting
method. Our lead product candidate, Twirla®, (ethinyl
estradiol and levonorgestrel transdermal system), also known as
AG200-15, is a once-weekly prescription contraceptive
patch that recently completed Phase 3 trials. Twirla is based
on our proprietary transdermal patch technology, called
Skinfusion®, which is designed to provide advantages over currently
available patches and is intended to optimize
patch adhesion and patient wearability. For more
information, please visit the company website at
www.agiletherapeutics.com.
Contact: Mary Coleman 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From May 2023 to May 2024